ArticlePloS one2013

Pomalidomide shows significant therapeutic activity against CNS lymphoma with a major impact on the tumor microenvironment in murine models.

Zhimin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.